These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7996428)

  • 1. Electrophysiological and radioligand binding studies of elgodipine and derivatives in portal vein myocytes.
    Lepretre N; Arnaudeau S; Mironneau J; Rakotoarisoa L; Mironneau C; Galiano A
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1209-15. PubMed ID: 7996428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of Ca2+ channels in smooth muscle.
    Mironneau J
    Z Kardiol; 1991; 80 Suppl 7():43-6. PubMed ID: 1665262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine kinases modulate the activity of single L-type calcium channels in vascular smooth muscle cells from rat portal vein.
    Liu H; Sperelakis N
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1063-8. PubMed ID: 9365814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.
    Hamilton SL; Yatani A; Brush K; Schwartz A; Brown AM
    Mol Pharmacol; 1987 Mar; 31(3):221-31. PubMed ID: 2436031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The voltage-dependent non-selective cation channel sensitive to the L-type calcium channel blocker efonidipine regulates Ca2+ influx in brain vascular smooth muscle cells.
    Matsuoka T; Nishizaki T; Nomura T
    Biochem Biophys Res Commun; 1997 Nov; 240(2):484-7. PubMed ID: 9388505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of L-type Ca2+ channels in portal vein myocytes by the enantiomers of oxodipine.
    Baron A; Rakotoarisoa L; Leprêtre N; Mironneau J
    Eur J Pharmacol; 1994 Sep; 269(1):105-13. PubMed ID: 7828652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of voltage-gated L-type calcium channels by labedipinedilol-A involves protein kinase C in rat cerebrovascular smooth muscle cells.
    Wu BN; Chen ML; Dai ZK; Lin YL; Yeh JL; Wu JR; Chen IJ
    Vascul Pharmacol; 2009; 51(2-3):65-71. PubMed ID: 19298869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic nucleotides regulate the activity of L-type calcium channels in smooth muscle cells from rat portal vein.
    Liu H; Xiong Z; Sperelakis N
    J Mol Cell Cardiol; 1997 May; 29(5):1411-21. PubMed ID: 9201626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydropyridine binding and calcium channel function in clonal rat adrenal medullary tumor cells.
    Kunze DL; Hamilton SL; Hawkes MJ; Brown AM
    Mol Pharmacol; 1987 Apr; 31(4):401-9. PubMed ID: 2437436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
    Zheng W; Rampe D; Triggle DJ
    Mol Pharmacol; 1991 Nov; 40(5):734-41. PubMed ID: 1719369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
    Wei XY; Rutledge A; Triggle DJ
    Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oxodipine and elgodipine on (+)-[3H]-isradipine binding to cardiac and vascular membranes: cardiovascular selectivity.
    Rakotoarisoa L; Leprêtre N; Mironneau J; Galiano A; Mironneau C
    Fundam Clin Pharmacol; 1994; 8(6):546-52. PubMed ID: 7721232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
    Liu J; Bangalore R; Rutledge A; Triggle DJ
    Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged depolarization increases the pharmacological effect of dihydropyridines and their binding affinity for calcium channels of vascular smooth muscle.
    Morel N; Godfraind T
    J Pharmacol Exp Ther; 1987 Nov; 243(2):711-5. PubMed ID: 2824756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrendipine inhibition of calcium current in rat vascular muscle cells.
    Hermsmeyer K; Sturek M; Rusch NJ
    J Cardiovasc Pharmacol; 1988; 12 Suppl 5():S100-3. PubMed ID: 2469865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenoverine inhibition of calcium channel currents in single smooth muscle cells from rat portal vein and myometrium.
    Mironneau J; Arnaudeau S; Mironneau C
    Br J Pharmacol; 1991 Sep; 104(1):65-70. PubMed ID: 1786520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marrubenol interacts with the phenylalkylamine binding site of the L-type calcium channel.
    El Bardai S; Hamaide MC; Lyoussi B; Quetin-Leclercq J; Morel N; Wibo M
    Eur J Pharmacol; 2004 May; 492(2-3):269-72. PubMed ID: 15178374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dihydropyridines on calcium channels in isolated smooth muscle cells from rat vena cava.
    Mironneau J; Yamamoto T; Sayet I; Arnaudeau S; Rakotoarisoa L; Mironneau C
    Br J Pharmacol; 1992 Feb; 105(2):321-8. PubMed ID: 1373097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.